{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:12:19Z","timestamp":1791490339706,"version":"4.3.4"},"reference-count":144,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fibrinolysis is an important process in hemostasis responsible for dissolving the clot during wound healing. Plasmin is a central enzyme in this process via its capacity to cleave fibrin. The kinetics of plasmin generation (PG) and inhibition during fibrinolysis have been poorly understood until the recent development of assays to quantify these metrics. The assessment of plasmin kinetics allows for the identification of fibrinolytic dysfunction and better understanding of the relationships between abnormal fibrin dissolution and disease pathogenesis. Additionally, direct measurement of the inhibition of PG by antifibrinolytic medications, such as tranexamic acid, can be a useful tool to assess the risks and effectiveness of antifibrinolytic therapy in hemorrhagic diseases. This review provides an overview of available PG assays to directly measure the kinetics of plasmin formation and inhibition in human and mouse plasmas and focuses on their applications in defining the role of plasmin in diseases, including angioedema, hemophilia, rare bleeding disorders, COVID-19, or diet-induced obesity. Moreover, this review introduces the PG assay as a promising clinical and research method to monitor antifibrinolytic medications and screen for genetic or acquired fibrinolytic disorders.<\/jats:p>","DOI":"10.3390\/ijms22052758","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T06:22:32Z","timestamp":1615270952000},"page":"2758","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Assessing Plasmin Generation in Health and Disease"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-4007","authenticated-orcid":false,"given":"Adam","family":"Miszta","sequence":"first","affiliation":[{"name":"Synapse Research Institute, 6217 KD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Huskens","sequence":"additional","affiliation":[{"name":"Synapse Research Institute, 6217 KD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demy","family":"Donkervoort","sequence":"additional","affiliation":[{"name":"Synapse Research Institute, 6217 KD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly J. M.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Synapse Research Institute, 6217 KD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-2303","authenticated-orcid":false,"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[{"name":"Synapse Research Institute, 6217 KD Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Hajjar","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0014-5793(87)81501-6","article-title":"Molecular cloning and characterization of a full-length cDNA clone for human plasminogen","volume":"213","author":"Forsgren","year":"1987","journal-title":"FEBS Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1055\/s-0038-1660505","article-title":"Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review","volume":"2","author":"Remijn","year":"2018","journal-title":"TH Open"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00018-010-0566-5","article-title":"The plasmin-antiplasmin system: Structural and functional aspects","volume":"68","author":"Schaller","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1016\/S0021-9258(17)38992-5","article-title":"A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo","volume":"260","author":"Holvoet","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.83.18.6776","article-title":"Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor","volume":"83","author":"Ny","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/S0021-9258(18)61414-0","article-title":"cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta","volume":"262","author":"Ye","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3324\/haematol.2019.237966","article-title":"uPA-mediated plasminogen activation is enhanced by polyphosphate","volume":"106","author":"Whyte","year":"2020","journal-title":"Haematologica"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1073\/pnas.82.15.4939","article-title":"Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes","volume":"82","author":"Stoppelli","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1749-6632.2001.tb03512.x","article-title":"Fibrin-mediated plasminogen activation","volume":"936","author":"Nieuwenhuizen","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00001721-200212000-00007","article-title":"The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism","volume":"13","author":"Brown","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0021-9258(19)75687-7","article-title":"Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)","volume":"262","author":"Holmes","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.V58.6.1069.1069","article-title":"The presence and release of alpha 2-antiplasmin from human platelets","volume":"58","author":"Plow","year":"1981","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.129.2.315","article-title":"The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C\u20191r subcomponent of the first component of complement by serum C\u20191 esterase inhibitor","volume":"129","author":"Ratnoff","year":"1969","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-4165(84)90040-0","article-title":"Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor","volume":"802","author":"Thorsen","year":"1984","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI107967","article-title":"Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin","volume":"55","author":"Harpel","year":"1975","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03401685","article-title":"Degradation of C1-inhibitor by plasmin: Implications for the control of inflammatory processes","volume":"3","author":"Wallace","year":"1997","journal-title":"Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001721-200101000-00011","article-title":"The inhibition of TNK-t-PA by C1-inhibitor","volume":"12","author":"Sulikowski","year":"2001","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"33s","DOI":"10.1378\/chest.124.3_suppl.33S","article-title":"Thrombin and fibrinolysis","volume":"124","author":"Nesheim","year":"2003","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1160\/TH03-04-0291","article-title":"Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis","volume":"90","author":"Suelves","year":"2003","journal-title":"Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2741\/1503","article-title":"Alpha-enolase plasminogen receptor in myogenesis","volume":"10","author":"Suelves","year":"2005","journal-title":"Front Biosci"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1074\/jbc.273.23.14503","article-title":"\u03b1-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci","volume":"273","author":"Pancholi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"353687","DOI":"10.1155\/2012\/353687","article-title":"The Biochemistry and Regulation of S100A10: A Multifunctional Plasminogen Receptor Involved in Oncogenesis","volume":"2012","author":"Madureira","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1096\/fj.201901490RR","article-title":"Plasmin inhibition by bacterial serpin: Implications in gum disease","volume":"34","author":"Ksiazek","year":"2020","journal-title":"Faseb J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MBC.0b013e32833c9a9f","article-title":"Plasmin-induced procoagulant effects in the blood coagulation: A crucial role of coagulation factors V and VIII","volume":"21","author":"Ogiwara","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1074\/jbc.274.13.8500","article-title":"Plasmin Converts Factor X from Coagulation Zymogen to Fibrinolysis Cofactor*","volume":"274","author":"Pryzdial","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen Is a Complement Inhibitor","volume":"287","author":"Barthel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1432-1033.1996.0682d.x","article-title":"Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor","volume":"236","author":"Kost","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1334483","article-title":"Plasminogen receptors: The first quarter century","volume":"39","author":"Miles","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tmrv.2014.09.006","article-title":"The Fibrinolytic System\u2014More Than Fibrinolysis?","volume":"29","author":"Draxler","year":"2015","journal-title":"Transfus. Med. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1538-7836.2007.02464.x","article-title":"Fibrinolysis, inflammation, and regulation of the plasminogen activating system","volume":"5","author":"Medcalf","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/jth.13849","article-title":"Fibrinolysis: From blood to the brain","volume":"15","author":"Medcalf","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0036-1598000","article-title":"Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential","volume":"43","author":"Kwaan","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jcp.49.12.958","article-title":"Hyperfibrinolysis","volume":"49","author":"Hunt","year":"1996","journal-title":"J. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm0396-287","article-title":"Impaired wound healing in mice with a disrupted plasminogen gene","volume":"2","author":"Bugge","year":"1996","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0002-9440(10)65060-2","article-title":"Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction","volume":"156","author":"Creemers","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.18632\/oncotarget.375","article-title":"Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis","volume":"2","author":"Madureira","year":"2011","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/bjc.1998.261","article-title":"Increased plasminogen binding is associated with metastatic breast cancer cells: Differential expression of plasminogen binding proteins","volume":"77","author":"Ranson","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood.V99.8.2835","article-title":"Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo","volume":"99","author":"Suelves","year":"2002","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1073\/pnas.94.18.9779","article-title":"Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin","volume":"94","author":"Tsirka","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0092-8674(00)80483-3","article-title":"Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin","volume":"91","author":"Chen","year":"1997","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0035-1550437","article-title":"The Fibrinolytic Status in Liver Diseases","volume":"41","author":"Leebeek","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.2019004267","article-title":"A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice","volume":"135","author":"Miszta","year":"2020","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/jth.13859","article-title":"Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice","volume":"15","author":"Tersteeg","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S1474-4422(18)30323-5","article-title":"The role of plasminogen activators in stroke treatment: Fibrinolysis and beyond","volume":"17","author":"Thiebaut","year":"2018","journal-title":"Lancet. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.ATV.19.3.499","article-title":"Relationship of Plasmin Generation to Cardiovascular Disease Risk Factors in Elderly Men and Women","volume":"19","author":"Sakkinen","year":"1999","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","article-title":"Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications","volume":"129","author":"Moore","year":"2019","journal-title":"Anesth. Analg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.4049\/jimmunol.172.9.5765","article-title":"Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin","volume":"172","author":"Yang","year":"2004","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","article-title":"Enhanced clearance of A\u03b2 in brain by sustaining the plasmin proteolysis cascade","volume":"105","author":"Jacobsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuron.2006.04.013","article-title":"Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity","volume":"50","author":"Samson","year":"2006","journal-title":"Neuron"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/153537020422901103","article-title":"New functions for an old enzyme: Nonhemostatic roles for tissue-type plasminogen activator in the central nervous system","volume":"229","author":"Yepes","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH04-12-0838","article-title":"Tissue plasminogen activator in central nervous system physiology and pathology","volume":"93","author":"Melchor","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11739-020-02443-8","article-title":"COVID-19: The crucial role of blood coagulation and fibrinolysis","volume":"15","author":"Coccheri","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2016.02.021","article-title":"Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations","volume":"138","author":"Suffritti","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","first-page":"583","article-title":"Plasmin generation and D-dimer formation during cardiopulmonary bypass","volume":"15","author":"Chandler","year":"2004","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ye, Y., Vattai, A., Zhang, X., Zhu, J., Thaler, C.J., Mahner, S., Jeschke, U., and von Sch\u00f6nfeldt, V. (2017). Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081651"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/10245332.2018.1470069","article-title":"Characteristics of fibrinolytic disorders in acute promyelocytic leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematolgy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V91.6.2005","article-title":"Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice","volume":"91","author":"Ploplis","year":"1998","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1538-7836.2004.00916.x","article-title":"A central role for plasminogen in the inflammatory response to biomaterials","volume":"2","author":"Busuttil","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0092-8674(82)90220-3","article-title":"Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor","volume":"28","author":"Chapman","year":"1982","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation Testing in the Core Laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"de Laat-Kremers, R.M.W., Ninivaggi, M., Devreese, K.M.J., and de Laat, B. (2020). Towards standardization of thrombin generation assays: Inventory of thrombin generation methods based on results of an International Society of Thrombosis and Haemostasis Scientific Standardization Committee survey. J. Thromb. Haemost.","DOI":"10.1111\/jth.14863"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/rth2.12048","article-title":"A review of commercially available thrombin generation assays","volume":"2","author":"Kintigh","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0028-1104546","article-title":"Standardization and clinical utility of thrombin-generation assays","volume":"34","author":"Berntorp","year":"2008","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjh.14796","article-title":"Diagnosis of inherited bleeding disorders in the genomic era","volume":"179","author":"Sivapalaratnam","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.blre.2012.06.001","article-title":"Thrombin generation: What have we learned?","volume":"26","author":"Hemker","year":"2012","journal-title":"Blood Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0036-1572327","article-title":"Alterations in Fibrin Structure in Patients with Liver Diseases","volume":"42","author":"Lisman","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1160\/TH15-10-0801","article-title":"Simultaneous measurement of thrombin generation and fibrin formation in whole blood under flow conditions","volume":"116","author":"Kelchtermans","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: From research to routine diagnostic assays","volume":"16","author":"Longstaff","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: Technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.23736\/S0375-9393.19.13687-5","article-title":"Comparison between thromboelastography and thromboelastometry","volume":"85","author":"Sakai","year":"2019","journal-title":"Minerva Anestesiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccc.2016.09.002","article-title":"Management of Trauma-Induced Coagulopathy with Thrombelastography","volume":"33","author":"Gonzalez","year":"2017","journal-title":"Crit. Care Clin."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2516.2010.02451.x","article-title":"Standardization of thromboelastography: A report from the TEG-ROTEM working group","volume":"17","author":"Chitlur","year":"2011","journal-title":"Haemophilia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365513.2013.801509","article-title":"Monitoring fibrinolysis in whole blood by viscoelastic instruments: A comparison of ROTEM and ReoRox","volume":"73","author":"Nilsson","year":"2013","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/00365513.2014.993698","article-title":"Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox\u00ae) versus thromboelastometry (ROTEM\u00ae)","volume":"75","author":"Solomon","year":"2015","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"Loof","year":"2011","journal-title":"Hematology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2516.2012.02759.x","article-title":"Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders","volume":"18","author":"Menegatti","year":"2012","journal-title":"Haemophilia"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2011.04541.x","article-title":"Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency","volume":"167","author":"Cugno","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.thromres.2010.12.011","article-title":"Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults","volume":"127","author":"Simpson","year":"2011","journal-title":"Thromb. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","article-title":"Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis","volume":"110","author":"Matsumoto","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-019-01869-y","article-title":"Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin","volume":"48","author":"Tarandovskiy","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.02.013","article-title":"C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin","volume":"176","author":"Tarandovskiy","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41598-020-60436-1","article-title":"Interspecies comparison of simultaneous thrombin and plasmin generation","volume":"10","author":"Tarandovskiy","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1160\/TH08-01-0029","article-title":"The technique of measuring thrombin generation with fluorogenic substrates: 1. Necessity of adequate calibration","volume":"100","author":"Spronk","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2012.10.011","article-title":"Data management in thrombin generation","volume":"131","author":"Hemker","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/hae.13842","article-title":"Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency","volume":"25","author":"Saes","year":"2019","journal-title":"Haemophilia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/jth.15106","article-title":"Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation","volume":"18","author":"Valke","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity","volume":"41","author":"Bouck","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"De Jongh, R., Ninivaggi, M., Mesotten, D., Bai, C., Marcus, B., Huskens, D., Stragier, H., Miszta, A., Verbruggen, J., and de Laat-Kremers, R.M.W. (2021). Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU. Blood Coagul. Fibrinolysis, Publish Ahead of Print.","DOI":"10.1097\/MBC.0000000000001007"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2516.2007.01588.x","article-title":"A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency","volume":"14","author":"Maino","year":"2008","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"ref_98","first-page":"178","article-title":"Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis","volume":"43","author":"Lisman","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.85.5.1822","article-title":"Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor","volume":"85","author":"Ridker","year":"1992","journal-title":"Circulation"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0037-1615594","article-title":"Fibrinolytic variables in patients with recurrent venous thrombosis: A prospective cohort study","volume":"85","author":"Crowther","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_101","first-page":"191","article-title":"alpha2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke","volume":"43","author":"Reed","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.V95.9.2855.009k02_2855_2859","article-title":"Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis","volume":"95","author":"Rosendaal","year":"2000","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0895-4356(03)00052-0","article-title":"Prospective study of fibrinolytic markers and venous thromboembolism","volume":"56","author":"Folsom","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1538-7836.2007.02409.x","article-title":"A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations","volume":"5","author":"Matsuo","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Casanave, E.B., and Tentoni, J. (2014). Comparative fibrinolysis. Fibrinolysis Thrombolysis, Available online: https:\/\/www.intechopen.com\/books\/fibrinolysis-and-thrombolysis\/comparative-fibrinolysis.","DOI":"10.5772\/57359"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(00)81390-2","article-title":"Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency","volume":"87","author":"Bugge","year":"1996","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.thromres.2014.08.007","article-title":"Active PAI-1 as marker for venous thromboembolism: Case\u2013control study using a comprehensive panel of PAI-1 and TAFI assays","volume":"134","author":"Bollen","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2007.02717.x","article-title":"Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation","volume":"5","author":"Sperzel","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/j.1538-7836.2012.04925.x","article-title":"Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator","volume":"10","author":"Silva","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000000789","article-title":"What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies","volume":"30","author":"Picetti","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/TA.0b013e31825c1234","article-title":"Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration","volume":"73","author":"Cotton","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0036-1598001","article-title":"Diagnosis and Treatment of Hyperfibrinolysis in Trauma (A European Perspective)","volume":"43","author":"Gall","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2362.1984.tb01198.x","article-title":"Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator","volume":"14","author":"Stibbe","year":"1984","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/bja\/aes361","article-title":"Haemostatic monitoring during postpartum haemorrhage and implications for management","volume":"109","author":"Solomon","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000331705","article-title":"Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: A case series and review of the literature","volume":"81","author":"Hyman","year":"2011","journal-title":"Oncology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial","volume":"376","author":"collaborators","year":"2010","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bmj.2.5809.311","article-title":"Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease","volume":"2","author":"Forbes","year":"1972","journal-title":"Br. Med. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2009-11-254045","article-title":"A new plasminogen receptor","volume":"115","author":"Strickland","year":"2010","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"33125","DOI":"10.1074\/jbc.M111.218693","article-title":"The Novel Plasminogen Receptor, Plasminogen ReceptorKT (Plg-RKT), Regulates Catecholamine Release","volume":"286","author":"Bai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1046\/j.1538-7836.2003.00155.x","article-title":"Endogenous plasmin converts Glu-plasminogen to Lys-plasminogen on the monocytoid cell surface","volume":"1","author":"Zhang","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1050-1738(02)00190-1","article-title":"Critical Role for Conversion of Glu-Plasminogen to Lys-Plasminogen for Optimal Stimulation of Plasminogen Activation on Cell Surfaces","volume":"13","author":"Miles","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1172\/JCI113814","article-title":"Binding of Lys-plasminogen to monocytes\/macrophages","volume":"82","author":"Silverstein","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.2020007263","article-title":"Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets","volume":"137","author":"Whyte","year":"2021","journal-title":"Blood"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI118404","article-title":"Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide","volume":"97","author":"Samad","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"18063","DOI":"10.1074\/jbc.M310462200","article-title":"Integrin \u03b1M\u03b22 Orchestrates and Accelerates Plasminogen Activation and Fibrinolysis by Neutrophils","volume":"279","author":"Pluskota","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-2141.1996.7482367.x","article-title":"Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a)","volume":"95","author":"Dudani","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1172\/JCI112529","article-title":"Plasminogen interacts with human platelets through two distinct mechanisms","volume":"77","author":"Miles","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2003-09-3016","article-title":"Characterization of plasminogen as an adhesive ligand for integrins alphaMbeta2 (Mac-1) and alpha5beta1 (VLA-5)","volume":"104","author":"Lishko","year":"2004","journal-title":"Blood"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1242\/jcs.108.3.1071","article-title":"A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines","volume":"108","author":"Hembrough","year":"1995","journal-title":"J. Cell Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1074\/jbc.M004919200","article-title":"Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a","volume":"276","author":"Hawley","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1021\/bi060756w","article-title":"Identification of histone H2B as a regulated plasminogen receptor","volume":"45","author":"Herren","year":"2006","journal-title":"Biochemistry"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1016\/S0021-9258(19)36575-5","article-title":"Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation","volume":"268","author":"Parkkinen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1016\/S0021-9258(18)99093-9","article-title":"Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen","volume":"266","author":"Kanalas","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1242\/jcs.114.5.917","article-title":"Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices","volume":"114","author":"Davis","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0036-1592301","article-title":"Microparticles and Fibrinolysis","volume":"43","author":"Vallier","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1074\/jbc.272.27.17216","article-title":"Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells","volume":"272","author":"Ginestra","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood-2009-06-228817","article-title":"Fibrinolytic cross-talk: A new mechanism for plasmin formation","volume":"115","author":"Dejouvencel","year":"2010","journal-title":"Blood"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","article-title":"Elements of the Fibrinolytic System","volume":"936","author":"Lijnen","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/ALN.0000000000001997","article-title":"Antifibrinolytic Therapy and Perioperative Considerations","volume":"128","author":"Levy","year":"2018","journal-title":"Anesthesiology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0037-1616122","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/01.CIR.85.5.1706","article-title":"Platelet-dependent thrombin generation after in vitro fibrinolytic treatment","volume":"85","author":"Aronson","year":"1992","journal-title":"Circulation"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.thromres.2015.06.008","article-title":"Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab","volume":"136","author":"Barteling","year":"2015","journal-title":"Thromb. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2758\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:24Z","timestamp":1760160924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":144,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijms22052758"],"URL":"https:\/\/doi.org\/10.3390\/ijms22052758","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}